New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action

被引:137
作者
Tsiang, Manuel [1 ]
Jones, Gregg S. [1 ]
Niedziela-Majka, Anita [1 ]
Kan, Elaine [1 ]
Lansdon, Eric B. [1 ]
Huang, Wayne [1 ]
Hung, Magdeleine [1 ]
Samuel, Dharmaraj [1 ]
Novikov, Nikolai [1 ]
Xu, Yili [1 ]
Mitchell, Michael [1 ]
Guo, Hongyan [1 ]
Babaoglu, Kerim [1 ]
Liu, Xiaohong [1 ]
Geleziunas, Romas [1 ]
Sakowicz, Roman [1 ]
机构
[1] Gilead Sci Inc, Foster City, CA 94404 USA
关键词
VIRUS TYPE-1 INTEGRASE; SMALL-MOLECULE INHIBITORS; DNA-BINDING DOMAIN; PEPTIDE INHIBITORS; VIRAL-DNA; IN-VITRO; LEDGF/P75; DISCOVERY; REVEALS; PROTEIN;
D O I
10.1074/jbc.M112.347534
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
tert-Butoxy-(4-phenyl-quinolin-3-yl)-acetic acids (tBPQA) are a new class of HIV-1 integrase (IN) inhibitors that are structurally distinct from IN strand transfer inhibitors but analogous to LEDGINs. LEDGINs are a class of potent antiviral compounds that interacts with the lens epithelium-derived growth factor (LEDGF) binding pocket on IN and were identified through competition binding against LEDGF.LEDGF tethers IN to the host chromatin and enables targeted integration of viral DNA. The prevailing understanding of the antiviral mechanism of LEDGINs is that they inhibit LEDGF binding to IN, which prevents targeted integration of HIV-1. We showed that in addition to the properties already known for LEDGINs, the binding of tBPQAs to the IN dimer interface inhibits IN enzymatic activity in a LEDGF-independent manner. Using the analysis of two long terminal repeat junctions in HIV-infected cells, we showed that the inhibition by tBPQAs occurs at or prior to the viral DNA 3'-processing step. Biochemical studies revealed that this inhibition operates by compound-induced conformational changes in the IN dimer that prevent proper assembly of IN onto viral DNA. For the first time, tBPQAs were demonstrated to be allosteric inhibitors of HIV-1 IN displaying a dual mode of action: inhibition of IN-viral DNA assembly and inhibition of IN-LEDGF interaction.
引用
收藏
页码:21189 / 21203
页数:15
相关论文
共 64 条
[41]   Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers [J].
Maroun, RG ;
Gayet, S ;
Benleulmi, MS ;
Porumb, H ;
Zargarian, L ;
Merad, H ;
Leh, H ;
Mouscadet, JF ;
Troalen, FR ;
Fermandjian, S .
BIOCHEMISTRY, 2001, 40 (46) :13840-13848
[42]  
Mathias A., 2009, 16 C RETR OPP INF MO, P79
[43]   Dynamic Modulation of HIV-1 Integrase Structure and Function by Cellular Lens Epithelium-derived Growth Factor (LEDGF) Protein [J].
McKee, Christopher J. ;
Kessl, Jacques J. ;
Shkriabai, Nikolozi ;
Dar, Mohd Jamal ;
Engelman, Alan ;
Kvaratskhelia, Mamuka .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (46) :31802-31812
[44]   Resistance to Integrase Inhibitors [J].
Metifiot, Mathieu ;
Marchand, Christophe ;
Maddali, Kasthuraiah ;
Pommier, Yves .
VIRUSES-BASEL, 2010, 2 (07) :1347-1366
[45]   Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers [J].
Min, Sherene ;
Song, Ivy ;
Borland, Julie ;
Chen, Shuguang ;
Lou, Yu ;
Fujiwara, Tamio ;
Piscitelli, Stephen C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) :254-258
[46]   Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain [J].
Molteni, V ;
Greenwald, J ;
Rhodes, D ;
Hwang, Y ;
Kwiatkowski, W ;
Bushman, FD ;
Siegel, JS ;
Choe, S .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2001, 57 :536-544
[47]   Processing of X-ray diffraction data collected in oscillation mode [J].
Otwinowski, Z ;
Minor, W .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :307-326
[48]   A historical sketch of the discovery and development of HIV-1 integrase inhibitors [J].
Savarino, Andrea .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (12) :1507-1522
[49]  
Shimura Kazuya, 2009, Antiviral Chemistry & Chemotherapy, V20, P79, DOI 10.3851/IMP1397
[50]  
Steigbigel R., 2008, 15 C RETR OPP INF BO, P357